BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25902438)

  • 21. Molecular mechanism of sphingomyelin-specific membrane binding and pore formation by actinoporins.
    Bakrac B; Anderluh G
    Adv Exp Med Biol; 2010; 677():106-15. PubMed ID: 20687484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical Synthesis and Characterization of an Equinatoxin II(1-85) Analogue.
    Karas JA; Sani MA; Separovic F
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28358312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential interaction of equinatoxin II with model membranes in response to lipid composition.
    Caaveiro JM; Echabe I; Gutiérrez-Aguirre I; Nieva JL; Arrondo JL; González-Mañas JM
    Biophys J; 2001 Mar; 80(3):1343-53. PubMed ID: 11222295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The behavior of sea anemone actinoporins at the water-membrane interface.
    García-Ortega L; Alegre-Cebollada J; García-Linares S; Bruix M; Martínez-Del-Pozo A; Gavilanes JG
    Biochim Biophys Acta; 2011 Sep; 1808(9):2275-88. PubMed ID: 21621507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic tryptophan fluorescence of equinatoxin II, a pore-forming polypeptide from the sea anemone Actinia equina L, monitors its interaction with lipid membranes.
    Macek P; Zecchini M; Pederzolli C; Dalla Serra M; Menestrina G
    Eur J Biochem; 1995 Nov; 234(1):329-35. PubMed ID: 8529661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteine-scanning mutagenesis of an eukaryotic pore-forming toxin from sea anemone: topology in lipid membranes.
    Anderluh G; Barlic A; Podlesek Z; Macek P; Pungercar J; Gubensek F; Zecchini ML; Serra MD; Menestrina G
    Eur J Biochem; 1999 Jul; 263(1):128-36. PubMed ID: 10429196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary structure of a pore-forming toxin from the sea anemone, Actinia equina L., and its association with lipid vesicles.
    Belmonte G; Menestrina G; Pederzolli C; Krizaj I; Gubensek F; Turk T; Macek P
    Biochim Biophys Acta; 1994 Jun; 1192(2):197-204. PubMed ID: 7912550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equinatoxin II permeabilizing activity depends on the presence of sphingomyelin and lipid phase coexistence.
    Schön P; García-Sáez AJ; Malovrh P; Bacia K; Anderluh G; Schwille P
    Biophys J; 2008 Jul; 95(2):691-8. PubMed ID: 18390598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelin.
    Bakrac B; Kladnik A; Macek P; McHaffie G; Werner A; Lakey JH; Anderluh G
    J Biol Chem; 2010 Jul; 285(29):22186-95. PubMed ID: 20463009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new cytolytic protein from the sea anemone Urticina crassicornis that binds to cholesterol- and sphingomyelin-rich membranes.
    Razpotnik A; Krizaj I; Kem WR; Macek P; Turk T
    Toxicon; 2009 Jun; 53(7-8):762-9. PubMed ID: 19232528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sea anemone actinoporins: the transition from a folded soluble state to a functionally active membrane-bound oligomeric pore.
    Alegre-Cebollada J; Oñaderra M; Gavilanes JG; del Pozo AM
    Curr Protein Pept Sci; 2007 Dec; 8(6):558-72. PubMed ID: 18220843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane damage by an α-helical pore-forming protein, Equinatoxin II, proceeds through a succession of ordered steps.
    Rojko N; Kristan KČ; Viero G; Žerovnik E; Maček P; Dalla Serra M; Anderluh G
    J Biol Chem; 2013 Aug; 288(33):23704-15. PubMed ID: 23803608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of lipids on the structure of the eukaryotic cytolysin equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.
    Miles AJ; Drechsler A; Kristan K; Anderluh G; Norton RS; Wallace BA; Separovic F
    Biochim Biophys Acta; 2008 Oct; 1778(10):2091-6. PubMed ID: 18440301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sticholysin II: a pore-forming toxin as a probe to recognize sphingomyelin in artificial and cellular membranes.
    Garcia PS; Chieppa G; Desideri A; Cannata S; Romano E; Luly P; Rufini S
    Toxicon; 2012 Oct; 60(5):724-33. PubMed ID: 22677808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence analysis of the cDNA encoding the precursor of equinatoxin V, a newly discovered hemolysin from the sea anemone Actinia equina.
    Pungercar J; Anderluh G; Macek P; Franc G; Strukelj B
    Biochim Biophys Acta; 1997 Sep; 1341(2):105-7. PubMed ID: 9357951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of an α-pore-forming toxin depends on the assembly mechanism on the target membrane as revealed by single molecule imaging.
    Subburaj Y; Ros U; Hermann E; Tong R; García-Sáez AJ
    J Biol Chem; 2015 Feb; 290(8):4856-4865. PubMed ID: 25525270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photobleaching reveals heterogeneous stoichiometry for equinatoxin II oligomers.
    Baker MA; Rojko N; Cronin B; Anderluh G; Wallace MI
    Chembiochem; 2014 Sep; 15(14):2139-45. PubMed ID: 25138674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Avidin-FITC topological studies with three cysteine mutants of equinatoxin II, a sea anemone pore-forming protein.
    Anderluh G; Barlic A; Krizaj I; Menestrina G; Gubensĕk F; Macek P
    Biochem Biophys Res Commun; 1998 Jan; 242(1):187-90. PubMed ID: 9439633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupting a key hydrophobic pair in the oligomerization interface of the actinoporins impairs their pore-forming activity.
    Mesa-Galloso H; Delgado-Magnero KH; Cabezas S; López-Castilla A; Hernández-González JE; Pedrera L; Alvarez C; Peter Tieleman D; García-Sáez AJ; Lanio ME; Ros U; Valiente PA
    Protein Sci; 2017 Mar; 26(3):550-565. PubMed ID: 28000294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.